P
ZURA icon

Pfizer’s Zura Bio ZURA Stock Holding History

Pfizer’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8M Sell
2,838,913
-131,109
-4% -$792K 7.05% 5
2025
Q4 		$15.6M Hold
2,970,022
– – 6.58% 6
2025
Q3 		$12.9M Hold
2,970,022
– – 2.94% 9
2025
Q2 		$3.12M Hold
2,970,022
– – 0.54% 13
2025
Q1 		$3.83M Hold
2,970,022
– – 0.77% 11
2024
Q4 		$7.43M Buy
+2,970,022
New +$10.6M 0.29% 13

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pfizer's ZURA Position: Q1 2026 in Review

Pfizer reduced its Zura Bio (ZURA) stake by 4.4% in Q1 2026, selling an estimated $792K and leaving 2,838,913 shares worth $16.8M. The position accounts for 7.05% of the portfolio, ranked #5.

Pfizer first reported a position in ZURA in Q4 2024 and has held it in 6 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Pfizer held 2,838,913 shares of Zura Bio worth $16.8M as of Q1 2026.
  • Pfizer sold 131,109 Zura Bio shares in Q1 2026, an estimated $792K.
  • Zura Bio made up 7.05% of Pfizer's portfolio in Q1 2026, its #5 holding.
  • Pfizer first reported a position in Zura Bio in Q4 2024 and has held it in 6 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Pfizer's 13F filing for Q1 2026, filed 12 May 2026.